Biblio

Export 83 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is U  [Clear All Filters]
2018
C. E. Gleason, Norton, D., Anderson, E. D., Wahoske, M., Washington, D. T., Umucu, E., Koscik, R. L., N Dowling, M., Johnson, S. C., Carlsson, C. M., and Asthana, S., Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker., J Alzheimers Dis, vol. 61, no. 1, pp. 79-89, 2018.
M. Nakanishi, Hirooka, K., Imai, Y., Inoue, S., Yukari, Y., Katayama, C., Miyamoto, Y., Shindo, Y., Ueno, H., Toya, J., Takano, Y., and Nishida, A., Dementia Care Competence Among Care Professionals and Reduced Challenging Behavior of Home-Dwelling Persons with Dementia: A Pre- and Post-Intervention Data Analysis., J Alzheimers Dis, vol. 64, no. 2, pp. 515-523, 2018.
B. Gurel, Cansev, M., Sevinc, C., Kelestemur, S., Ocalan, B., Cakir, A., Aydin, S., Kahveci, N., Ozansoy, M., Taskapilioglu, O., Ulus, I. Hakki, Başar, M. Karayel, Sahin, B., Tuzuner, M. Bora, and Baykal, A. Tarik, Early Stage Alterations in CA1 Extracellular Region Proteins Indicate Dysregulation of IL6 and Iron Homeostasis in the 5XFAD Alzheimer's Disease Mouse Model., J Alzheimers Dis, vol. 61, no. 4, pp. 1399-1410, 2018.
N. Ito, Saito, H., Seki, S., Ueda, F., and Asada, T., Effects of Composite Supplement Containing Astaxanthin and Sesamin on Cognitive Functions in People with Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial., J Alzheimers Dis, vol. 62, no. 4, pp. 1767-1775, 2018.
A. Suzuki, Shinozaki, J., Yazawa, S., Ueki, Y., Matsukawa, N., Shimohama, S., and Nagamine, T., Establishing a New Screening System for Mild Cognitive Impairment and Alzheimer's Disease with Mental Rotation Tasks that Evaluate Visuospatial Function., J Alzheimers Dis, vol. 61, no. 4, pp. 1653-1665, 2018.
A. Gámez-Valero, Canet-Pons, J., Urbizu, A., Anillo, A., Santos, C., Ariza, A., and Beyer, K., INDEL Length and Haplotypes in the β-Synuclein Gene: A Key to Differentiate Dementia with Lewy Bodies?, J Alzheimers Dis, vol. 65, no. 1, pp. 207-219, 2018.
J. D. Finan, Udani, S. V., Patel, V., and Bailes, J. E., The Influence of the Val66Met Polymorphism of Brain-Derived Neurotrophic Factor on Neurological Function after Traumatic Brain Injury., J Alzheimers Dis, vol. 65, no. 4, pp. 1055-1064, 2018.
J. M. Zolezzi, Lindsay, C. B., Serrano, F. G., Ureta, R. C., Theoduloz, C., Schmeda-Hirschmann, G., and Inestrosa, N. C., Neuroprotective Effects of Ferruginol, Jatrophone, and Junicedric Acid Against Amyloid-β Injury in Hippocampal Neurons., J Alzheimers Dis, vol. 63, no. 2, pp. 705-723, 2018.
I. Piaceri, Imperiale, D., Ghidoni, E., Atzori, C., Bagnoli, S., Ferrari, C., Ungari, S., Ambrogio, L., Sorbi, S., and Nacmias, B., Novel GRN Mutations in Alzheimer's Disease and Frontotemporal Lobar Degeneration., J Alzheimers Dis, vol. 62, no. 4, pp. 1683-1689, 2018.
O. Tene, Hallevi, H., Korczyn, A. D., Shopin, L., Molad, J., Kirschbaum, C., Bornstein, N. M., Shenhar-Tsarfaty, S., Kliper, E., Auriel, E., Usher, S., Stalder, T., and Ben Assayag, E., The Price of Stress: High Bedtime Salivary Cortisol Levels Are Associated with Brain Atrophy and Cognitive Decline in Stroke Survivors. Results from the TABASCO Prospective Cohort Study., J Alzheimers Dis, vol. 65, no. 4, pp. 1365-1375, 2018.
B. Soukupova Urbanova, Schwabova, J. Paulasova, Magerova, H., Jansky, P., Marková, H., Vyhnálek, M., Laczó, J., Hort, J., and Tomek, A., Reduced Cerebrovascular Reserve Capacity as a Biomarker of Microangiopathy in Alzheimer's Disease and Mild Cognitive Impairment., J Alzheimers Dis, vol. 63, no. 2, pp. 465-477, 2018.
Y. Hasegawa, Toyama, K., Uekawa, K., Ichijo, H., and Kim-Mitsuyama, S., Role of ASK1/p38 Cascade in a Mouse Model of Alzheimer's Disease and Brain Aging., J Alzheimers Dis, vol. 61, no. 1, pp. 259-263, 2018.
S. Klöppel, Kotschi, M., Peter, J., Egger, K., Hausner, L., Frölich, L., Förster, A., Heimbach, B., Normann, C., Vach, W., Urbach, H., and Abdulkadir, A., Separating Symptomatic Alzheimer's Disease from Depression based on Structural MRI., J Alzheimers Dis, vol. 63, no. 1, pp. 353-363, 2018.
R. Pluta, Ułamek-Kozioł, M., Januszewski, S., and Czuczwar, S. J., Tau Protein Dysfunction after Brain Ischemia., J Alzheimers Dis, vol. 66, no. 2, pp. 429-437, 2018.
I. Akushevich, Yashkin, A. P., Kravchenko, J., Ukraintseva, S., Stallard, E., and Yashin, A. I., Time Trends in the Prevalence of Neurocognitive Disorders and Cognitive Impairment in the United States: The Effects of Disease Severity and Improved Ascertainment., J Alzheimers Dis, vol. 64, no. 1, pp. 137-148, 2018.
T. Sao, Yoshino, Y., Yamazaki, K., Ozaki, Y., Mori, Y., Ochi, S., Yoshida, T., Mori, T., Iga, J. - I., and Ueno, S. - I., TREM1 mRNA Expression in Leukocytes and Cognitive Function in Japanese Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 64, no. 4, pp. 1275-1284, 2018.
2017
W. H. Bouvy, Kuijf, H. J., Zwanenburg, J. J. M., Koek, H. L., L Kappelle, J., Luijten, P. R., M Ikram, K., and Biessels, G. Jan, Abnormalities of Cerebral Deep Medullary Veins on 7 Tesla MRI in Amnestic Mild Cognitive Impairment and Early Alzheimer's Disease: A Pilot Study., J Alzheimers Dis, vol. 57, no. 3, pp. 705-710, 2017.
C. Robb, Udeh-Momoh, C., Wagenpfeil, S., Schöpe, J., Alexopoulos, P., and Perneczky, R., Biomarkers and Functional Decline in Prodromal Alzheimer's Disease., J Alzheimers Dis, vol. 58, no. 1, pp. 69-78, 2017.
S. P. Arnerić, Batrla-Utermann, R., Beckett, L., Bittner, T., Blennow, K., Carter, L., Dean, R., Engelborghs, S., Genius, J., Gordon, M. Forrest, Hitchcock, J., Kaplow, J., Luthman, J., Meibach, R., Raunig, D., Romero, K., Samtani, M. N., Savage, M., Shaw, L., Stephenson, D., Umek, R. M., Vanderstichele, H., Willis, B., and Yule, S., Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team., J Alzheimers Dis, vol. 55, no. 1, pp. 19-35, 2017.
D. A. Ferro, van Veluw, S. J., Koek, H. L., Exalto, L. G., and Biessels, G. Jan, Cortical Cerebral Microinfarcts on 3 Tesla MRI in Patients with Vascular Cognitive Impairment., J Alzheimers Dis, vol. 60, no. 4, pp. 1443-1450, 2017.
R. Kotani, Urano, Y., Sugimoto, H., and Noguchi, N., Decrease of Amyloid-β Levels by Curcumin Derivative via Modulation of Amyloid-β Protein Precursor Trafficking., J Alzheimers Dis, vol. 56, no. 2, pp. 529-542, 2017.
J. Morris K, Uy, R. Adeline Z., Vidoni, E. D., Wilkins, H. M., Archer, A. E., Thyfault, J. P., Miles, J. M., and Burns, J. M., Effect of APOE ε4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease., J Alzheimers Dis, vol. 58, no. 4, pp. 1129-1135, 2017.
K. Yamazaki, Yoshino, Y., Mori, T., Yoshida, T., Ozaki, Y., Sao, T., Mori, Y., Ochi, S., Iga, J. - I., and Ueno, S. - I., Gene Expression and Methylation Analysis of ABCA7 in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 57, no. 1, pp. 171-181, 2017.
L. J. C. van Wa van Doorn, Gispert, J. D., H Kuiperij, B., Claassen, J. A. H. R., Arighi, A., Baldeiras, I., Blennow, K., Bozzali, M., Castelo-Branco, M., Cavedo, E., Emek-Savaş, D. D., Eren, E., Eusebi, P., Farotti, L., Fenoglio, C., Ormaechea, J. Fortea, Freund-Levi, Y., Frisoni, G. B., Galimberti, D., Genc, S., Greco, V., Hampel, H., Herukka, S. - K., Liu, Y., Lladó, A., Lleo, A., Nobili, F. M., Oguz, K. K., Parnetti, L., Pereira, J., Picco, A., Pikkarainen, M., de Oliveira, C. Resende, Saka, E., Salvadori, N., Sánchez-Valle, R., Santana, I., Scarpini, E., Scheltens, P., Soininen, H., Tarducci, R., Teunissen, C., Tsolaki, M., Urbani, A., Vilaplana, E., Visser, P. Jelle, Wallin, A. K., Yener, G., Molinuevo, J. L., Meulenbroek, O., and Verbeek, M. M., Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes., J Alzheimers Dis, vol. 56, no. 2, pp. 543-555, 2017.

Pages